Updating Assumptions and Setting Priorities for APAC’s Healthcare Market in 2026

Join us in Singapore at the Conrad Singapore Orchard!

Our Q1 APAC Healthcare Executive Roundtable will bring together MedTech, Diagnostics, and Pharma executives to pressure test assumptions for 2026 market performance across Asia Pacific’s healthcare systems. This will be a critical moment to reassess targets, pressure test strategies, and benchmark assumptions and tactics with peer executives. During the moderated discussion, we will provide updated assumptions on key inputs to market growth forecasts including the outlook for key trends impacting pricing and reimbursement, while focusing on strategic imperatives for P&L holders to ensure commercial outperformance across 2026.